![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Training von Patienten mit linksventrikulären mechanischen Herzunterstützungsystemen und nach Herztransplantation
Patienten nach LVAD-Implantation benötigen eine intensive interdisziplinäre Betreuung und Überwachung zur Vermeidung und Behandlung von Device-spezifischen Komplikationen. In den ersten Monaten nach Implantati...
-
Chapter and Conference Paper
Patients Undergoing ICD Implantation: How Many Need Biventricular Pacing?
The goal of ICD therapy is to prevent premature sudden cardiac death (SCD) in patients who would otherwise have a long-term survival expectancy. The major challenge is to detect the greatest number of patients...
-
Chapter and Conference Paper
Ventricular Resynchronization: What May We Expect from Technological Advances?
Cardiac resynchronization therapy (CRT) with biventricular pacing has been recently explored as an adjunctive support to drugs to treat symptoms in patients with advanced heart failure (HF) (NYHA class III-IV)...
-
Chapter and Conference Paper
Hemodynamic Sensors: What Clinical Value Do They Have in Chronotropic Incompetence?
The physiological capacity to regulate heart rate according to changing metabolic needs is impaired to a various degree in all clinical forms of sick sinus syndrome (SSS), as well as in the presence of patholo...
-
Chapter and Conference Paper
Hemodynamic Sensors: What Clinical Value Do They Have in Heart Failure?
Up to recent years, electrical pacing has mainly been intended as a therapeutic tool in the treatment of cardiac rhythm disorders due to either atrial disorders or atrioventricular conduction defects. In order...
-
Chapter and Conference Paper
Does Atrial Resynchronization Confer Further Benefit on Patients Undergoing Ventricular Resynchronization Therapy?
Congestive heart failure is considered to be one of the most important public health problems in cardiovascular medicine. In the United States, more than 3 million people are afflicted by the disease, with nea...
-
Chapter and Conference Paper
The “Pill in the Pocket” Approach for Paroxysmal Atrial Fibrillation: How Effective and Safe Is It?
The occurrence of paroxysmal atrial fibrillation (AFib) is frequently associated with symptoms mainly due to the fast ventricular rate. In patients with nonva-lvular AFib therapy is based on drugs which slow t...
-
Chapter and Conference Paper
Antiplatelet Agents for Prevention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One?
Atrial fibrillation (AF) carries a high risk of systemic embolism, in particular stroke. This is true not only when AF is associated with valvular heart disease, but also in patients with nonvalvular AF, which...
-
Chapter and Conference Paper
Blutdruckvariabilität bei Sportlern
Blutdruckvariabilität ist Scit langem Gegenstand intensiver Studien (9, 13), obwohl ihre klinische Bedeutung bislang noch nicht vollständig definiert werden konnte (8, 11). Es wurde gezeigt, daß physische Akti...
-
Chapter and Conference Paper
Wirkungen einer einmaligen intravenösen Dosis von Nicergolin auf hämorheologische und hämodynamische Parameter bei peripheren Gefäßerkrankungen
Periphere obliterierende arterielle Erkrankungen (im weiteren Text als POAD—peripheral obliterative disease —abgekürzt) sind pathophysiologisch durch eine Reduktion der nutritiven Durchblutung gekennzeichnet, ...